MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

CRDF Cardiff Oncology Forecast, Technical & Fundamental Analysis

a cancer medicine oncology therapeutics company, which engages in the development of drugs that target cell division (mitosis), for the treatment of various cancers including leukemia, lymphomas, and solid tumors

Industry Biotechnology
CRDF
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For CRDF
(Try 14 days for Free)
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CRDF
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For CRDF
(Try 14 days for Free)
Ad is loading...
A.I. Advisor
published Earnings

CRDF is expected to report earnings to -25 cents per share on February 27

Cardiff Oncology CRDF Stock Earnings Reports
Q4'24
Est.
$-0.25
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.01
Q1'24
Beat
by $0.03
Q4'23
Beat
by $0.06
The last earnings report on November 07 showed earnings per share of -25 cents, beating the estimate of -27 cents. With 3.44M shares outstanding, the current market capitalization sits at 298.03M.
A.I. Advisor
published General Information

General Information

a cancer medicine oncology therapeutics company, which engages in the development of drugs that target cell division (mitosis), for the treatment of various cancers including leukemia, lymphomas, and solid tumors

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11055 Flintkote Avenue
Phone
+1 858 952-7570
Employees
32
Web
https://www.cardiffoncology.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

CRDF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CRDF has been loosely correlated with CMRX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CRDF jumps, then CMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDF
1D Price
Change %
CRDF100%
+32.75%
CMRX - CRDF
40%
Loosely correlated
-3.44%
AKBLF - CRDF
37%
Loosely correlated
N/A
VRPX - CRDF
32%
Poorly correlated
-3.94%
BEAM - CRDF
31%
Poorly correlated
-1.21%
CMPX - CRDF
31%
Poorly correlated
+2.68%
More